Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA

INTRODUCTION. We report detailed safety analyses by geographic region from the phase III study CLEOPATRA with pertuzumab, trastuzumab, and docetaxel in patients with human epidermal growth factor receptor 2 (HER2)-positive first-line metastatic breast cancer. PATIENTS AND METHODS. Patients received...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Swain, Sandra M., Im, Young-Hyuck, Im, Seock-Ah, Chan, Valorie, Miles, David, Knott, Adam, Clark, Emma, Ross, Graham, Baselga, José
Materialtyp: Artigo
Språk:Inglês
Publicerad: AlphaMed Press 2014
Ämnen:
Breast Cancer
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077449/
https://ncbi.nlm.nih.gov/pubmed/24869931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0033
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk